eCART vs Ceribell

Ward medicine leaders who want a cleared deterioration score get eCART, and it comes with a published comparison. A 2024 JAMA Network Open study of six early warning scores at Yale New Haven Health, covering more than 362,000 ward encounters, ranked it most accurate, and its authors include eCART developers. The clearance (K233253) is for hospitalized adults on wards, and access runs through a demo request.

Ceribell goes to hospitals, ICUs and emergency departments that want point-of-care EEG: a bedside headband and recorder, seizure detection the vendor says covers 25-week preterm neonates to adults, and a delirium monitor. The company is public (Nasdaq: CBLL) and reported 712 active accounts and $28.1 million revenue for the second quarter of 2026. Sixteen 510(k) records sit under its name. Ward deterioration scoring and EEG-based seizure and delirium detection answer different clinical questions, and Ceribell's terms run one year, renewing yearly unless the hospital gives 90 days' notice.